← Eichor
Study identifier: NCT07420478 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

TF-CBT for Autistic Youth Pilot Implementation - Open Pilot

Condition: Autism Spectrum Disorder · PTSD and Trauma-related Symptoms · Autism  ·  Sponsor: Dartmouth-Hitchcock Medical Center

PhaseNA
Planned participants24
Who can joinAll sexes, 6 Years to no upper limit
Healthy volunteersNo

About this study

Compared to the general population, autistic youth are at increased risk for both exposure to potentially traumatic events and trauma-related symptoms following trauma exposure. Autistic people identify approaches to effectively addressing trauma as a top mental health research priority, yet providers in community settings often report inadequate training in trauma treatment. The purpose of this study is to conduct an open pilot to evaluate the feasibility and acceptability of an evidence-based intervention for youth affected by trauma, Trauma-Focused Cognitive Behavioral Therapy (TF-CBT), that has been modified for autistic youth served in Community Mental Health Centers.

This description comes directly from the study's public registry record.

Talk to the study team

Kaitlyn Ahlers, PhD  ·  603-650-7075  ·  kaitlyn.p.ahlers@hitchcock.org

Always discuss trial participation with your own doctor first.

Locations (1)

Dartmouth Hitchcock Medical CenterLebanon, New Hampshire, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07420478